SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
南瓜
Lv3
300 积分
2021-06-22 加入
最近求助
最近应助
互助留言
Real-world Data on First-line Systemic Therapy for Hormone Receptor-positive HER2-negative Metastatic Breast Cancer: A Trend Shift in the Era of CDK 4/6 Inhibitors
12天前
已完结
Pyrotinib in combination with first-line trastuzumab and docetaxel for patients with HER2-positive metastatic breast cancer: a new therapeutic option?
16天前
已完结
Androgen receptor agonism in advanced oestrogen receptor-positive breast cancer
16天前
已完结
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
30天前
已完结
The CDK4/6 inhibitor revolution - a game-changing era for breast cancer treatment
1个月前
已完结
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
2个月前
已完结
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
2个月前
已完结
Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature
2个月前
已完结
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
2个月前
已完结
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
2个月前
已完结
没有进行任何应助
下载不到已经初版格式的文献【积分已退回】
3个月前
不想要Journal Pre-proof版本
3个月前
不想要Journal Pre-proof版本
3个月前
找不到【积分已退回】
5个月前
找不到【积分已退回】
5个月前
重新求助【积分已退回】
1年前
非常感谢
2年前
并不是该文献的全文
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论